Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
Patient retention is a hugely important factor for clinical trials and is just as vital as patient recruitment. A high retention rate of patients is critical for the validity and credibility of your clinical trial, and you don’t want your hard work to overcome recruitment challenges and enrol patients to go to waste
As a company committed to accelerating patient access to life-changing therapies through effective and market-specific clinical trial patient recruitment and retention strategies, it was a natural step for Innovative Trials to expand its operations into the US by opening an office in Raleigh’s famous Research Triangle in North Carolina. Two years on, Eloise
Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial
The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere vary every year, but it is usually from October to May, with peaks of activity between December and May (CDC). This seasonal aspect
Clinical trial patient recruitment and retention remains a persistent challenge for the biopharmaceutical industry. Even now, more than four in five studies miss their deadline to recruit enough clinical trial patients – a statistic that has remained largely unchanged for more than 15 years. Why the UK government must continue investment to boost
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and
Clinical trial patient recruitment and retention remains a persistent challenge for the biopharmaceutical industry. Even now, more than four in five studies miss their deadline to recruit enough clinical trial patients – a statistic that has remained largely unchanged for more than 15 years. Our CEO and founder, Kate Shaw, spoke with Leanne
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and
As clinical trial patient recruitment and retention experts, we know how challenging and time-consuming this can be for sites. In an earlier blog post, we shared how we can help solve some of the biggest patient recruitment challenges that both sponsors and sites can face. During a recent webinar, we fielded several pressing